Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

James Baker, MD - Speaker

Principal Investigator – Aimmune Therapeutics, Inc., Amgen, AstraZeneca, Biocryst, Circassia, CSL Behring, Dyax, GlaxoSmithKline, Merck, Mylan, Optinose, Pearl, Pharming, Sanofi-Aventis, Shire, Stallergens, Teva

Spouse – Maruho Co. Ltd, Novartis, Pfizer, Prominus Pharma, Regeneron, Watson Laboratories

Jonathan Corren, MD – Speaker

Consultant – Genentech, Regeneron

Advisory committee member – Genentech, Sanofi, Teva, Novartis

Thomas A. Fleisher, MD, FAAAAI, FACAAI – Speaker

Co-editor – Elsevier: Clinical Immunology: Principles and Practice 4^th ed

Donald Y. M. Leung, MD, PhD – Speaker

Consultant – Sanofi Genzyme,  Regeneron

Contracted Research – Medimmune

James L. Sublett, MD, FACAAI – Speaker

Board member – AllergyZone,

Speaker/Teacher – Genentech, Boston Scientific, Circassia, Meda, Kaleo

Advisory Committee member – AstraZeneca

Robert Eitches, MD – Planner

Speaker – Merck

Marilyn Li, MD – Planner

Speaker – Meda

Travis Miller, MD – Planner

Speaker – AstraZeneca, Genentech, Meda, Mylan

Advisory Board – Meda, Kaleo

Research – Teva

Madeline Ramos, MD – Planner

Speaker – Teva

Raffi Tachdjian, MD – Planner

Speaker – CSL Behring, Shire, Pharming, Alcon, Teva, Mylan

Advisory – CSL Behring, Shire, Teva

Research Grant – Shire

The following have no relevant financial relationships to disclose:

Yvonne Huang, MD – Speaker

Tiffany Jean, MD – Speaker

Sheila Bonilla, MD, MS – Presenter, Planner

Christina Schwindt, MD – Presenter, Planner, Reviewer

Karol Anderson – Planner

Vinay Gowda, MD – Planner

Vincent Tubiolo, MD – Planner